المؤلفون: Springuel, Lorraine, Lonez, Caroline, Alexandre, Bertrand, Van Cutsem, Eric, Machiels, Jean-Pascal H., Van Den Eynde, Marc, Prenen, Hans, Hendlisz, Alain, Shaza, Leila, Carrasco, Javier, Canon, Jean-Luc, Opyrchal, Mateusz, Odunsi, Kunle, Rottey, Sylvie, Gilham, David E., Flament, Anne, Lehmann, Frederic F.

المصدر: BIODRUGS ; ISSN: 1173-8804 ; ISSN: 1179-190X

مصطلحات موضوعية: Medicine and Health Sciences, ANTITUMOR-ACTIVITY, PHASE-I, ADOPTIVE IMMUNOTHERAPY, CHECKPOINT, BLOCKADE, DOSE-ESCALATION, CANCER, EXPRESSION, GENE, THERAPY, LYMPHOCYTES

وصف الملف: application/pdf

العلاقة: https://biblio.ugent.be/publication/8653706Test; http://hdl.handle.net/1854/LU-8653706Test; http://dx.doi.org/10.1007/s40259-019-00368-zTest; https://biblio.ugent.be/publication/8653706/file/8653710Test

الإتاحة: https://doi.org/10.1007/s40259-019-00368-zTest
https://biblio.ugent.be/publication/8653706Test
http://hdl.handle.net/1854/LU-8653706Test
https://biblio.ugent.be/publication/8653706/file/8653710Test

المؤلفون: Van den Eynde, Marc, Mlecnik, Bernhard, Bindea, Gabriela, Fredriksen, Tessa, Church, Sarah E, Lafontaine, Lucie, Haicheur, Nacilla, Marliot, Florence, Angelova, Mihaela, Vasaturo, Angela, Bruni, Daniela, Mourin, Anne, Baldin, Paméla, Huyghe, Nicolas, Haustermans, Karin, Debucquoy, Annelies, Van Cutsem, Eric, Gigot, Jean-François, Hubert, Catherine, Kartheuser, Alex, Remue, Christophe, Léonard, Daniel, Valge-Archer, Viia, Pagès, Franck, Machiels, Jean-Pascal, Galon, Jérôme

المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie, UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation, UCL - (SLuc) Service de chirurgie et transplantation abdominale, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Unité d'oncologie médicale, UCL - (SLuc) Centre du cancer

المصدر: Cancer cell, Vol. 34, no. 6, p. 1012-1026.e3 (2018)

مصطلحات موضوعية: Immunoscore, PDL1, T cells, biopsy, cancer, colorectal cancer, metastasis, prediction, tumor microenvironment, tumor-immunology

العلاقة: boreal:208578; http://hdl.handle.net/2078.1/208578Test; info:pmid/30537506; urn:ISSN:1535-6108; urn:EISSN:1878-3686

الإتاحة: https://doi.org/10.1016/j.ccell.2018.11.003Test
http://hdl.handle.net/2078.1/208578Test

المؤلفون: Kelly, Ronan J, Ajani, Jaffer A, Kuzdzal, Jaroslaw, Zander, Thomas, Van Cutsem, Eric, Piessen, Guillaume, Mendez, Guillermo, Feliciano, Josephine, Motoyama, Satoru, Lièvre, Astrid, Uronis, Hope, Elimova, Elena, Grootscholten, Cecile, Geboes, Karen, Zafar, Syed, Snow, Stephanie, Ko, Andrew H, Feeney, Kynan, Schenker, Michael, Kocon, Piotr, Zhang, Jenny, Zhu, Lili, Lei, Ming, Singh, Prianka, Kondo, Kaoru, Cleary, James M, Moehler, Markus, CheckMate 577 Investigators, Van den Eynde, Marc

المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Service d'hépato-gastro-entérologie, UCL - (SLuc) Service d'hématologie, Baylor University, MD Anderson Cancer Center [Houston], The University of Texas Health Science Center at Houston (UTHealth), Uniwersytet Jagielloński w Krakowie = Jagiellonian University (UJ), Universitätsklinikum Köln (Uniklinik Köln), Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), CHU Lille, Favaloro Foundation, Johns Hopkins University (JHU), Akita University, Chemistry, Oncogenesis, Stress and Signaling (COSS), Université de Rennes (UR)-CRLCC Eugène Marquis (CRLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], Duke Cancer Institute Durham, Duke University Medical Center, Princess Margaret Hospital, University of Toronto, Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek Hospital, Ghent University Hospital, Florida Hospital Cancer Institute, University of California [San Francisco] (UC San Francisco), University of California (UC), Bristol-Myers Squibb Company, Dana-Farber Cancer Institute [Boston], Johannes Gutenberg - Universität Mainz = Johannes Gutenberg University (JGU), Bristol Myers Squibb Bristol-Myers Squibb, Ono Pharmaceutical, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-CRLCC Eugène Marquis (CRLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM), University of California [San Francisco] (UCSF), University of California, Johannes Gutenberg - Universität Mainz (JGU)

المصدر: NEW ENGLAND JOURNAL OF MEDICINE
The New England journal of medicine, Vol. 384, no.13, p. 1191-1203 (2021)
New England Journal of Medicine
New England Journal of Medicine, 2021, 384 (13), pp.1191-1203. ⟨10.1056/NEJMoa2032125⟩
New England Journal of Medicine, Massachusetts Medical Society, 2021, 384 (13), pp.1191-1203. ⟨10.1056/NEJMoa2032125⟩

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Esophageal Neoplasms, medicine.medical_treatment, [SDV.CAN]Life Sciences [q-bio]/Cancer, Kaplan-Meier Estimate, Adenocarcinoma, 030204 cardiovascular system & hematology, Gastroenterology, B7-H1 Antigen, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Stomach Neoplasms, Internal medicine, Medicine and Health Sciences, medicine, Carcinoma, Humans, 030212 general & internal medicine, Esophagus, Immune Checkpoint Inhibitors, Neoadjuvant therapy, Aged, Aged, 80 and over, Chemotherapy, business.industry, Cancer, Chemoradiotherapy, Adjuvant, General Medicine, Middle Aged, medicine.disease, Neoadjuvant Therapy, Intention to Treat Analysis, 3. Good health, Nivolumab, medicine.anatomical_structure, Chemotherapy, Adjuvant, Carcinoma, Squamous Cell, Female, Esophagogastric Junction, business, Adjuvant, Chemoradiotherapy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4457a48c1298137ed58fc654dafd044cTest
https://doi.org/10.1056/nejmoa2032125Test

المؤلفون: Mansoor, Wasat, Arkenau, Hendrik-Tobias, Alsina, Maria, Shitara, Kohei, Thuss-Patience, Peter, Cuffe, Sinead, Dvorkin, Mikhail, Park, David, Ando, Takayuki, Van Den Eynde, Marc, Beretta, Giordano D., Zaniboni, Alberto, Doi, Toshihiko, Tabernero, Josep, Ilson, David H., Makris, Lukas, Benhadji, Karim A., Van Cutsem, Eric, Universitat Autònoma de Barcelona

المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Centre du cancer, UCL - (SLuc) Service de gastro-entérologie, UCL - (SLuc) Unité d'oncologie médicale

المصدر: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, Vol. 24, no.4, p. 970-977 (2021)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Gastric Cancer

مصطلحات موضوعية: Male, Cancer Research, Pyrrolidines, Trifluridine, tipiracil, Gastroenterology, chemistry.chemical_compound, Antineoplastic Combined Chemotherapy Protocols, Medicine, Neoplasm Metastasis, TAGS, Aged, 80 and over, Hazard ratio, Trifluridine/tipiracil, General Medicine, Middle Aged, Primary tumor, Survival Rate, Drug Combinations, Treatment Outcome, Oncology, Subgroup analysis, Female, Esophagogastric Junction, Life Sciences & Biomedicine, medicine.drug, Adult, medicine.medical_specialty, Short Communication, Placebo, Gastroesophageal junction cancer, Phase 3, Young Adult, Stomach Neoplasms, Internal medicine, Humans, Adverse effect, Tipiracil, Aged, Proportional Hazards Models, Science & Technology, Gastroenterology & Hepatology, business.industry, Cancer, medicine.disease, chemistry, business, Thymine

وصف الملف: Print-Electronic; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0e1fae9a679d0b6a9115ddf5b7bd603Test
https://hdl.handle.net/2078.1/261879Test

المؤلفون: Baurain, Jean-François, Cornelis, Frank, Duhoux, François, Humblet, Yves, Mazzeo, Filomena, Van den Eynde, Marc, Machiels, Jean-Pascal

المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Unité d'oncologie médicale, UCL - (SLuc) Centre du cancer

المصدر: Louvain médical, Vol. 135, no. 2, p. 21-24 (2016)

مصطلحات موضوعية: Cancer, Chemotherapy, Targeted agent, Immunotherapy, Multidisciplinary, Avancées majeures, Traitement, Chimiothérapie, Thérapies ciblées, Immunothérapie, Multidisciplinarité, Major advances, Treatment

العلاقة: boreal:173864; http://hdl.handle.net/2078.1/173864Test; urn:ISSN:0024-6956

الإتاحة: http://hdl.handle.net/2078.1/173864Test

المؤلفون: Gabriela Bindea, Lucie Lafontaine, Yves Humblet, Anne Jouret-Mourin, Najeeb Syed, Catherine Hubert, Alex Kartheuser, Mihaela Angelova, Daniela Bruni, Jérôme Galon, Michele Ceccarelli, Davide Bedognetti, Marc Van den Eynde, Bénédicte Buttard, Bernhard Mlecnik, Angela Vasaturo, Francesco M. Marincola, Erwan Morgand, Tessa Fredriksen

المساهمون: Angelova, Mihaela, Mlecnik, Bernhard, Vasaturo, Angela, Bindea, Gabriela, Fredriksen, Tessa, Lafontaine, Lucie, Buttard, Bénédicte, Morgand, Erwan, Bruni, Daniela, Jouret-Mourin, Anne, Hubert, Catherine, Kartheuser, Alex, Humblet, Yve, Ceccarelli, Michele, Syed, Najeeb, Marincola, Francesco M., Bedognetti, Davide, Van den Eynde, Marc, Galon, Jérôme

المصدر: Cell. 175(3)

مصطلحات موضوعية: 0301 basic medicine, Genetics and Molecular Biology (all), recurrence, Colorectal cancer, CD3, medicine.medical_treatment, immunoscore, Somatic evolution in cancer, Biochemistry, General Biochemistry, Genetics and Molecular Biology, Metastasis, immunoediting, 03 medical and health sciences, clonal, 0302 clinical medicine, Immune system, Lymphocytes, Tumor-Infiltrating, Leukemic Infiltration, Neoplasms, medicine, Tumor Microenvironment, Humans, Neoplasm Metastasis, Models, Statistical, biology, Cancer, T cell, Immunotherapy, medicine.disease, microenvironment, Tumor Burden, 030104 developmental biology, Immunoediting, 030220 oncology & carcinogenesis, Cancer research, biology.protein, metastasi, immunotherapy, heterogeneity, mutation

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::680b66c07f5003bc1071c15160e34e82Test
https://pubmed.ncbi.nlm.nih.gov/30566878Test